Thornhill Medical
Jaimin Shah is a Quality Specialist at Thornhill Medical since April 2024, with a solid foundation in quality management and control across various roles. Previous positions include Quality System Specialist and Quality Control Technician at Profound Medical Inc. from December 2020 to March 2024, as well as Quality Control Technician at Amico Group of Companies from November 2018 to December 2020. Jaimin is a certified ISO 13485:2016/MDSAP internal auditor, experienced in conducting internal audits and managing customer complaints. Early experience at BEIL Research and Consultancy Private Limited involved quality checks of incoming parts and coordinating the implementation of '5S' for improved productivity. Jaimin holds a postgraduate degree in quality engineering management from Lambton College, earned between 2017 and 2019.
Thornhill Medical
Briefly, what does your company do?*Thornhill, an innovative SME is the inventor, developer and supplier of novel and valuable healthcare systems and devices important in emergency, mobile, and remote/austere health delivery sectors. This includes EMS, Humanitarian, Public Safety and Military and other “challenging circumstance” applications.Thornhill is internationally recognized as a leader in the precise control and management of arterial blood gases. This expertise has allowed it to develop and supply a range of novel, IP protected, portable, medical systems that are able to provide critical life support functions to those deployed in challenging circumstances. Thornhill Medical delivers unique and valuable solutions that include 1) MOVES® SLC™: a portable life support for casualty care during patient transport, in field hospitals and forward surgical suites; 2) ClearMateTM: immediate and effective treatment for carbon monoxide poisoning; 3) MADMTM: mobile anesthesia; and 4) RespirAct™ RA-MR: an investigational tool used in diagnostic procedures which measure vascular reactivity.Thornhill differentiates itself in this market via its superior understanding of the utilization of arterial blood gases, thus eliminating, or substantially reducing the bulk, weight, cost and logistic burdens of other products, while optimizing patient outcomes. The efficacy of its solutions is recognized globally, with the United States Marine Corps, the Government of Ontario and the Federal Government of Canada being notable customers.